This inventor holds 1 USPTO granted patent. Top assignees: Ajinomoto Co., Ltd., Japanese Foundation for Cancer Research. Active years: 1995.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
1 out of 1,953 
1 out of 58 Years Active: 1995
Title: The Innovations of Masami Muramatsu
Introduction
Masami Muramatsu is a notable inventor based in Tokorozawa, US. She has made significant contributions to the field of biotechnology, particularly in the development of interleukin-2 polypeptides. Her work has implications for cancer research and immunotherapy.
Latest Patents
Masami Muramatsu holds a patent for recombinantly produced interleukin-2, which exhibits human IL-2 activity. This innovative polypeptide has a molecular weight of about 15,000 daltons and is stable at a pH range of 2-9. It is also resistant to elevated temperatures. The recombinant IL-2 primarily promotes the proliferation of cytotoxic T lymphocytes, making it a valuable asset in therapeutic applications.
Career Highlights
Throughout her career, Masami has worked with prominent organizations such as Ajinomoto Co., Ltd. and the Japanese Foundation for Cancer Research. Her expertise in biotechnology has allowed her to make impactful advancements in her field.
Collaborations
Masami has collaborated with esteemed colleagues, including Tadatsugu Taniguchi and Haruo Sugano. These partnerships have furthered her research and contributed to the success of her innovations.
Conclusion
Masami Muramatsu's work in the field of biotechnology, particularly her patent on interleukin-2 polypeptides, showcases her dedication to advancing medical science. Her contributions continue to influence cancer research and immunotherapy.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile